Loading…
Based on limited metadata without access to the full warning letter text, this FDA warning was issued to Dr. Balamurali K. Ambati regarding drug-related violations in August 2019. The specific nature of the violations cannot be determined from the available metadata, as no subject line details are provided. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is unknown. To understand the complete violations and regulatory concerns, review of the full warning letter text would be necessary.